CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza A Subtyping Kit
A Diagnostic Kit Related Image
(Not Necessarily related to the device)Description:
CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza A Subtyping Kit by Centers for Disease Control and Prevention (CDC)
The CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza A Subtyping Kit is a state-of-the-art diagnostic tool designed for the accurate detection and subtyping of the Influenza A virus. Manufactured by the esteemed Centers for Disease Control and Prevention (CDC), this kit is a paramount tool in the field of communicable diseases.
Filled with precision and reliable results, the kit uses Real-time Reverse Transcription Polymerase Chain Reaction (RT-PCR) technology, enabling fast and specific detection of different strains of influenza. This technology ensures that healthcare providers accurately diagnose patients, guiding the treatment process and facilitating the control of potential influenza outbreaks.
The major benefits of this subtyping kit include its potential to detect emerging flu strains, aiding in the surveillance of global influenza trends. It allows for prompt and accurate interventions, hence minimizing the public health impact of an influenza virus outbreak. The kit also provides valuable data to inform vaccine development and other preventive measures, contributing to the overall mission of public health safety.
Given its design, the CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza A Subtyping Kit is easy to use, providing quick results to healthcare professionals. Its robust nature makes it a necessary addition to any healthcare center in building defenses against the increasing threat of influenza outbreaks.
Primary Use:
Primary Medical Use of the CDC Human Inflivalence Virus Real-time RT-PCR Diagnostic Panel Influenza A Subtyping Kit
Designed meticulously for use in laboratories, the CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza A Subtyping Kit is a critical tool in the field of medical diagnostics and epidemiological research.This kit falls under the category of 'Sequencers', a class of medical equipment employed for determination and documentation of DNA or RNA sequences. In today's evolving medical landscape, where rapid, accurate, and highly sensitive detection of infectious pathogens has become paramount, such medical diagnostic equipment plays an essential role.
The key function of the CDC Influenza A Subtyping Kit is to provide a comprehensive diagnostic solution for the detection and subtyping of influenza A viruses. By leveraging Real-Time Reverse Transcription PCR (RT-PCR) technology, this kit can facilitate the identification of seasonal and novel H1N1 and H3N2 influenza viruses in a quick, efficient, and reliable manner. This functionality is essential for both routine diagnostic applications in medical settings and broader monitoring and surveillance initiatives instituted for infectious diseases control.
Appropriate utilization of this biomedical tool can not only aid in refining diagnostics, but also support the refinement of treatments and vaccination strategies, thus contributing significantly to the enhancement of public health. By providing accurate and rapid confirmation of the presence of influenza A viruses, the CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza A Subtyping Kit is truly a game-changer in modern medical diagnostics.
Equipped with this cutting-edge tool, doctors, and medical professionals can ensure more precise diagnostics, tailored treatments, and consequently, vastly improved patient care outcomes.
How It Works:
Understanding CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza A Subtyping Kit
The CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza A Subtyping Kit initiates an integral part in the diagnostic process of Influenza A, presenting rigorous and precise results necessary for the healthcare sphere.The Functionality of Real-time RT-PCR
Primarily, a Real-time RT-PCR functions by transcribing the RNA into complementary DNA (cDNA) using Reverse transcriptase. Afterward, the Polymerase Chain Reaction (PCR) phase amplifies specific DNA targets using short DNA fragments referred to as primers. This process is achieved through a cyclical heating and cooling of the mixture. Alongside these, probes marked with a fluorescent molecule bind to the target DNA, producing a fluorescent signal when the probe is degraded. This signal serves to quantify the amount of target DNA in the sample.Operational Mechanism of the CDC Panel
The CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel falls within a classification of high complexity diagnostic test systems requiring consistence with heavy regulation standards.Recognizing the influenza virus, the panel specifically amplifies viral genomic segments obtained from patient samples. It targets the influenza virus matrix protein gene and differentiates between Influenza A and B. Furthermore, the availability of protocols for influenza A subtyping allows these tests to discern H1, H3, and numerous other subtypes. This instrumentality ensures the accurate diagnosis and subsequent treatment.
Besides, the included controls assure the quality of the test, by confirming the correct functioning of the extraction process, and maintaining the absence of contamination in the reagents.
In conclusion, the CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza A Subtyping Kit plays an invaluable role in enabling healthcare professionals to deliver an accurate influenza diagnosis, thereby enabling the most appropriate patient management.
Manufacturer:
Centers for Disease Control and Prevention (CDC)
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.